|
Originally published In Press as doi:10.1074/jbc.M710089200 on March 24, 2008
J. Biol. Chem., Vol. 283, Issue 21, 14269-14276, May 23, 2008
Select Paramyxoviral V Proteins Inhibit IRF3 Activation by Acting as Alternative Substrates for Inhibitor of B Kinase (IKKe)/TBK1*
Lenette L. Lu ,
Mamta Puri¶,
Curt M. Horvath¶, and
Ganes C. Sen 1
From the
Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, the Graduate Program in Molecular Virology, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, and the ¶Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, Evanston, Illinois 60208
V accessory proteins from Paramyxoviruses are important in viral evasion of the innate immune response. Here, using a cell survival assay that identifies both inhibitors and activators of interferon regulatory factor 3 (IRF3)-mediated gene induction, we identified select paramyxoviral V proteins that inhibited double-stranded RNA-mediated signaling; these are encoded by mumps virus (MuV), human parainfluenza virus 2 (hPIV2), and parainfluenza virus 5 (PIV5), all members of the genus Rubulavirus. We showed that interaction between V and the IRF3/7 kinases, TRAF family member-associated NF B activator (TANK)-binding kinase 1 (TBK1)/inhibitor of B kinase (IKKe), was essential for this inhibition. Indeed, V proteins were phosphorylated directly by TBK1/IKKe, and this, intriguingly, resulted in lowering of the cellular level of V. Thus, it appears that V mimics IRF3 in both its phosphorylation by TBK1/IKKe and its subsequent degradation. Finally, a PIV5 mutant encoding a V protein that could not inhibit IKKe was much more susceptible to the antiviral effects of double-stranded RNA than the wild-type virus. Because many innate immune response signaling pathways, including those initiated by TLR3, TLR4, RIG-I, MDA5, and DNA-dependent activator of IRFs (DAI), use TBK1/IKKe as the terminal kinases to activate IRFs, rubulaviral V proteins have the potential to inhibit all of them.
Received for publication, December 11, 2007
, and in revised form, February 22, 2008.
* This work was supported, in whole or in part, by National Institutes of Health Grants CA62220 (to G. C. S.) and CA68782 (to G. C. S.) and Medical Scientist Training Grant GM07250 (to L. L. L.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 To whom correspondence should be addressed: Dept. of Molecular Genetics, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195. Tel.: 216-444-0636; Fax: 216-444-0513; E-mail: seng{at}ccf.org.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. C. Prins, W. B. Cardenas, and C. F. Basler
Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK{varepsilon} and TBK-1
J. Virol.,
April 1, 2009;
83(7):
3069 - 3077.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Childs, J. Andrejeva, R. E. Randall, and S. Goodbourn
Mechanism of mda-5 Inhibition by Paramyxovirus V Proteins
J. Virol.,
February 1, 2009;
83(3):
1465 - 1473.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Pfaller and K.-K. Conzelmann
Measles Virus V Protein Is a Decoy Substrate for I{kappa}B Kinase {alpha} and Prevents Toll-Like Receptor 7/9-Mediated Interferon Induction
J. Virol.,
December 15, 2008;
82(24):
12365 - 12373.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|